Tofogliflozin (hydrate)
目录号: A17860
SGLT2 抑制剂
托格列净水合物(CSG-452水合物)是一种强效且高度特异性的钠/葡萄糖共转运体2(SGLT2)抑制剂,其半抑制浓度(IC50)为2.9纳摩尔,对人类、大鼠和小鼠SGLT2的Ki值分别为2.9纳摩尔、14.9纳摩尔和6.4纳摩尔。
Discription | Tofogliflozin hydrate (CSG-452 hydrate) is a potent and highly specific sodium/glucose cotransporter 2 (SGLT2) inhibitor with an IC50 of 2.9 nM and Ki values of 2.9 nM, 14.9 nM, and 6.4 nM for human, rat, and mouse SGLT2. |
---|
目录号 | A17860 |
---|---|
分子式 | C22H28O7 |
分子量 | 404.45 |
CAS号 | 1201913-82-7 |
SMILES | O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@]21OCC3=C2C=C(CC4=CC=C(CC)C=C4)C=C3.O |
其他名称 | CSG-452 hydrate, CSG452, CSG 452 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 82 mg/mL (202.74 mM) | |
Water | 4 mg/mL (9.88 mM) | ||
Ethanol | 82 mg/mL (202.74 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 24.72 mL | 123.62 mL | 247.25 mL |
0.5 mM | 4.94 mL | 24.72 mL | 49.45 mL |
1 mM | 2.47 mL | 12.36 mL | 24.72 mL |
5 mM | 0.49 mL | 2.47 mL | 4.94 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2